Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06710236 · ClinicalTrials.gov registry record · NA
Evaluation of Investigational Hearing Instrument Features
A NA study, sponsored by Sonova.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06710236: Clinical Trial NA study, sponsored by Sonova.
NCT06710236 is a NA study that has not yet begun recruiting, run by Sonova. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06710236, a NA study, has not yet begun recruiting, sponsored by Sonova.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn how hearing instruments perform in varying environmental settings in adults with hearing loss. The main questions it aims to answer are: How do varying versions of hearing instrument features perform based on exposure to different environments? What is the hearing instrument user preference between varying versions of hearing instrument features? Participants will be fit with hearing instruments in the lab, and asked to wear them for the duration of the study period in their home environment. Participants will be asked to answer questionnaires throughout the study period.
Primary Outcome
Accuracy of hearing instrument feature performance based on environmental sampling and subjective reporting
Interventions
- DEVICE Hearing instrument
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-11-18 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
What is known before NCT06710236 opens enrollment
NCT06710236 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Hearing instrument is the first listed.
NCT06710236 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06710236 about?
NCT06710236 is a clinical study titled "Evaluation of Investigational Hearing Instrument Features". The goal of this clinical trial is to learn how hearing instruments perform in varying environmental settings in adults with hearing loss. The main questions it aims to answer are: How do varying versions of hearing instrument features perform based on exposure to different environments? What is th...
What is the current status of trial NCT06710236?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-11-18. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT06710236?
The interventions under investigation include: Hearing instrument (DEVICE).
Who is sponsoring clinical trial NCT06710236?
This trial is sponsored by Sonova, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06710236's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI